bf/NASDAQ:RDUS_icon.jpeg

COM:RADIUSPHARM

Radius Health

  • Stock

Last Close

19.82

08/11 17:28

Market Cap

406.74M

Beta: -

Volume Today

60.39K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    radiuspharm.com/
  • ipo date

    Jun 06, 2014

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment ...Show More

investor of